Critical reappraisal of current surveillance strategies for Barrett's esophagus: Analysis of a large German Barrett's database

Diseases of the Esophagus

Volumn 21, Issue 8, 2008, Pages 685-689

  Von Rahden, B H A ^a,b   Stein, H J ^a,b   Weber, A ^b   Vieth, M ^c   Stolte, M ^c   Rosch T ^b   Schmid, R M ^b   Sarbia, M ^d   Meining, Alexander ^b,e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Institute for Pathology   (Germany)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Barrett's esophagus; Dysplasia; Endoscopic surveillance; Esophageal adenocarcinoma; Intra epithelial neoplasia

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; CANCER INCIDENCE; CLINICAL PRACTICE; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLLOW UP; GERMANY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PATIENT MONITORING; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; COHORT STUDIES; DATABASES, FACTUAL; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; FEMALE; GERMANY; HUMANS; MALE; METAPLASIA; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 56349159636     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2008.00857.x     Document Type: Article

References (31)

1. Sampliner R E. The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-95.
2. Messmann H, Ell C, Fein M et al. [Topic Complex VI: Barrett esophagus.] Z Gastroenterol 2005; 43: 184-90.
3. Sharma P, McQuaid K, Dent J et al. AGA Chicago Workshop. A critical review of the diagnosis and management of Barrett's esophagus: The AGA Chirago Workshop. Gastroenterology 2004; 127: 310-30.
4. Spechler S J. Dysplasia in Barrett's esophagus: Limitations of current management strategies. Am J Gastroenterol 2005; 100: 927-35.
5. Spechler S J. Clinical practice. Barrett's esophagus. N Engl J Med 2002; 346: 836-42.
6. Stein H J, Feith M, Bruecher B L et al. Early esophageal cancer: Pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005; 242: 566-73.
7. Conio M, Blanchi S, Lapertosa G et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: A prospective study. Am J Gastroenterol 2003; 98: 1931-9.
8. Streitz J M Jr, Andrews C W Jr, Ellis F H Jr. Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993; 105: 383-7.
9. Peters J H, Clark G W, Ireland A P. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108: 813-22.
10. Heitmiller R F, Redmond M, Hamilton S R. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996; 224: 66-71.
11. van Sandick J W, van Lanschot J J, Kuiken B W etal. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998; 43: 216-22.
12. Aldulaimi D M, Cox M, Nwokolo C U et al. Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival. Eur J Gastroenterol Hepatol 2005; 17: 943-50.
13. van Blankenstein M. Barrett's esophagus: So what! Dis Esophagus 2002; 15: 1-4.
14. Quera R, O'Sullivan K, Quigley E M. Surveillance in Barrett's oesophagus: Will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma? Endoscopy 2006; 38: 162-9.
15. Inadomi J M, Sampliner R, Lagergren J et al. Screening and surveillance for Barrett esophagus in high-risk groups: A cost-utility analysis. Ann Intern Med 2003; 138: 176-86.
16. Shaheen N J, Crosby M A, Bozymski E M et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-8.
17. Hamilton S R, Aaltonen L A, (eds). Pathology and Genetics of Tumors of the Digestive System, Tumors of Small Intestine. Lyon: IARC Press, 2000; 69-91.
18. Kaplan E L, Meier P. Nonparametric estimation from incomplete observatons. J Am Stat Assoc 1958; 75: 457-87.
19. von Rahden B H A, Stein H J. Barrett's esophagus with high-grade intraepithelial neoplasia: Observation, ablation or resection? Eur Surg 2007; 39: 249-54.
20. Schnell T G, Sontag S J, Chejfec G et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-19.
21. Collard J M. High-grade dysplasia in Barrett's esophagus. The case for esophagectomy. Chest Surg Clin N Am 2002; 12: 77-92.
22. DeMeester T R. Surgical therapy for Barrett's esophagus: Prevention, protection and excision. Dis Esophagus 2002; 15: 109-16.
23. Zaninotto G, Parenti A R, Ruol A et al. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg 2000; 87: 1102-5.
24. Vieth M, Stolte M. Barrett's esophagus and neoplasia: Data from the Bayreuth Barrett's archive. Gastroenterology 2002; 122: 590-1.
25. Egger K, Werner M, Meining A et al. Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut 2003; 52: 18-23.
26. Schlemper R J, Riddell R H, Kato Y et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-5.
27. Sharma P, Falk G W, Weston A P et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006; 4: 566-72.
28. Jankowski J A, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology 2002; 122: 588-90.
29. Dulai G S, Shekelle P G, Jensen D M et al. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Am J Gastroenterol 2005; 100: 775-8.
30. Öberg S, Wenner J, Johansson J et al. Barrett esophagus: Risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 2005; 242: 49-54.
31. Weston A P, Sharma P, Mathur S et al. Risk stratification of Barrett's esophagus: Updated prospective multivariate analysis. Am J Gastroenterol 2004; 99: 1657-66.